Legend Biotech Corporation
LEGN
$35.35
-$0.28-0.79%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -125.38M | -100.92M | 26.28M | -125.32M | -18.20M |
| Total Depreciation and Amortization | 5.85M | 5.20M | 6.59M | 5.16M | 5.37M |
| Total Amortization of Deferred Charges | -- | -- | 206.00K | 314.00K | -- |
| Total Other Non-Cash Items | 142.08M | 65.55M | -35.08M | 61.42M | 8.10M |
| Change in Net Operating Assets | -35.59M | -73.59M | -80.08M | -17.39M | 3.08M |
| Cash from Operations | -13.04M | -103.75M | -82.08M | -75.82M | -1.65M |
| Capital Expenditure | -9.22M | -2.00M | -2.38M | -2.07M | -3.42M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -156.30M | 258.64M | -85.46M | 331.14M | -692.21M |
| Cash from Investing | -165.53M | 256.64M | -87.84M | 329.08M | -695.63M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.26M | -777.00K | -936.00K | -1.16M | -1.16M |
| Issuance of Common Stock | 273.00K | 1.44M | 603.00K | 5.41M | 2.12M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -990.00K | 667.00K | -333.00K | 4.25M | 955.00K |
| Foreign Exchange rate Adjustments | 4.44M | 1.40M | -2.28M | 524.00K | 9.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -175.12M | 154.95M | -172.53M | 258.02M | -696.32M |